2023 Exhibitors Search
Aston Sci. Inc.
Exhibit Item |
Bio · Medical · Pharma
|
---|---|
Country | Korea, South |
Tel (Rep.) | 02-2038-2347 |
Website | http://astonsci.com |
Company Introduction
Aston Sci. Inc. is a clinical-stage biopharmaceutical company led by a team of global pharmaceutical experts. Specializing in innovative immunotherapies, including therapeutic cancer vaccines, Aston Sci. focuses on enhancing T-cell immune responses against specific antigens, triggering cancer cell apoptosis. Central to our mission is the Th-Vac® platform. This platform, grounded in immune informatics, facilitates continuous epitope discovery, serving as the cornerstone of our ongoing efforts in therapeutic vaccine development.
Promotional Video
Exhibit Item
Exhibit Description
AST-021p
? Product Type: Peptide-based therapeutic cancer vaccine
? Mode of Action: Induction of Th1-cell immunity against HSP90
AST-301 (HER2 1+/2+ Breast Cancer)
? Product Type: Plasmid DNA based therapeutic cancer vaccine
? Mode of Action: Induction of Th1-cell immunity against HER2
Th-Vac™ Platform
? Product Type: Peptide-based therapeutic cancer vaccine
? Mode of Action: Induction of Th1-cell immunity against HSP90
AST-301 (HER2 1+/2+ Breast Cancer)
? Product Type: Plasmid DNA based therapeutic cancer vaccine
? Mode of Action: Induction of Th1-cell immunity against HER2
Th-Vac™ Platform
Co-Exhibitor or
Partner’s Information
Company Name | Country | Website |
---|